Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
Enhao Wang, Yang Li, Ruijie Ming, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 50
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Identification of Prognostic Biomarkers for Suppressing Tumorigenesis and Metastasis of Hepatocellular Carcinoma through Transcriptome Analysis
Divya Mishra, Ashish Mishra, Sachchida Nand, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 965-965
Open Access | Times Cited: 16
Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning
Md. Al Mehedi Hasan, Md. Maniruzzaman, Jungpil Shin
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle
Minhua Rong, Jian‐Di Li, Lu-Yang Zhong, et al.
Experimental Biology and Medicine (2021) Vol. 247, Iss. 5, pp. 395-408
Open Access | Times Cited: 31
The role of lnc‑MAPKAPK5‑AS1 in immune cell infiltration in hepatocellular carcinoma: Bioinformatics analysis and validation
Xiangzhi Hu, Dedong Wang, Jinbin Chen, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access
Statistical and machine learning based platform-independent key genes identification for hepatocellular carcinoma
Md. Al Mehedi Hasan, Md. Maniruzzaman, Jie Huang, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318215-e0318215
Open Access
Detection of reproducible liver cancer specific ligand-receptor signaling in blood
Aram Safrastyan, Damian Wollny
Frontiers in Bioinformatics (2025) Vol. 4
Open Access
The Predictive Competing Endogenous RNA Regulatory Networks and Potential Prognostic and Immunological Roles of Cyclin A2 in Pan-Cancer Analysis
Shengyong Chen, Zhijia Zhao, Xiaobo Wang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 15
A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification
Shenghao Li, Liyuan Hao, Xiaoyu Hu, et al.
Infectious Agents and Cancer (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 9
Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis
Md. Alim Hossen, Md. Selim Reza, Md. Harun-Or-Roshid, et al.
Current Cancer Drug Targets (2023) Vol. 23, Iss. 7, pp. 547-563
Closed Access | Times Cited: 8
Micronome Revealed miR-205-5p as Key Regulator of VEGFA During Cancer Related Angiogenesis in Hepatocellular Carcinoma
Abdulhakim Umar Toro, Sudheesh K. Shukla, Parveen Bansal
Molecular Biotechnology (2022) Vol. 65, Iss. 7, pp. 1178-1186
Closed Access | Times Cited: 10
Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
Mohib Ullah Kakar, Muhammad Zubair Mehboob, Muhammad Akram, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 8
Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics
Kaier Cai, Zhilong Xie, Yingao Liu, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 4
Combined transcriptomics and in-silico approach uncovers the role of prognostic biomarkers in hepatocellular carcinoma
Rubi Solanki, Prithvi Singh, Md Amjad Beg, et al.
Human Gene (2023) Vol. 35, pp. 201154-201154
Closed Access | Times Cited: 4
Eleven metabolism‑related genes composed of Stard5 predict prognosis and contribute to EMT phenotype in HCC
Dongping Li, Xiahui Lin, Jiale Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Transcriptomic Integration Analyses Uncover Common Bisphenol A Effects Across Species and Tissues Primarily Mediated by Disruption of JUN/FOS, EGFR, ER, PPARG, and P53 Pathways
Renjun Yang, Yuanping Lu, Nuoya Yin, et al.
Environmental Science & Technology (2023) Vol. 57, Iss. 48, pp. 19156-19168
Closed Access | Times Cited: 4
Neohesperidin promotes the osteogenic differentiation of bone mesenchymal stem cells by activating the Wnt/β-catenin signaling pathway
Yue-wen Chang, Wenjun Zhu, Wei Gu, et al.
Journal of Orthopaedic Surgery and Research (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 10
A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening
Min Chen, Guangbo Wu, Zhiwen Xie, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 5
Network pharmacological analysis of corosolic acid reveals P4HA2 inhibits hepatocellular carcinoma progression
Feifeng Tang, Long Liu, Xiaoting Tian, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Identification of BRIP1, NSMCE2, ANAPC7, RAD18 and TTL from chromosome segregation gene set associated with hepatocellular carcinoma
Ceren Sucularlı
Cancer Genetics (2022) Vol. 268-269, pp. 28-36
Closed Access | Times Cited: 4
Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma
Yangyang Zhang, Ruike Zhang, Lingxiu Zeng, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 3
5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease
Jin-Lin Chu, Shu‐Hong Bi, Yao He, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 3
Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma
Shaoyi Qiao, Wuhe Zhang, Yansheng Su, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Early-stage biomarkers identification by integrated genomic analysis in hepatocellular carcinoma
Suryaa Manoharan, Ekambaram Perumal
Medicine in Omics (2024) Vol. 12, pp. 100037-100037
Open Access
Page 1 - Next Page

Scroll to top